Home - News ( United States | United Kingdom | Italy | Germany ) - Football scores

Showing content from https://www.gileadadvancingaccess.com/hcp/faq below:

Frequently Asked Questions for Healthcare Professionals

Advancing Access is a patient support program that can provide information on coverage and financial support options for individuals who have been prescribed a Gilead HIV treatment, HIV prevention, or COVID-19 medication.

• Co-pay coupon card
• Patient Assistance Program/Medication Assistance Program (PAP/MAP)
• Benefits investigations
• Prior authorization and appeals process information
• Information on additional support and coverage options

Advancing Access program specialists can conduct a benefits investigation to help you and your patient understand their insurance coverage and any prior authorization or appeals process requirements. In Support Offerings and Resources, you will find sample letters of medical necessity and appeal, as well as a prior authorization checklist and claim forms.

If you or your staff would like to learn more about the Advancing Access program and the program support available to your patients, please call the program at 1-800-226-2056 to set up a training webinar.

• To enroll a patient in Advancing Access, you may use the HCP portal.
  • Go to the online enrollment portal and follow the on-screen instructions for enrolling a patient
  • By using the online enrollment portal, you can request assistance with a benefits investigation, submit an e-prescription and electronic prior authorization, or receive an immediate determination of your patient’s eligibility for the Patient Assistance Program/Medication Assistance Program (PAP/MAP)
• You can also fax an enrollment form, typically reviewed within 2 business days. The completed enrollment form should be faxed to the number on the form. Choose your patient’s enrollment form:
  • Advancing Access Program Enrollment Form (English)
  • Advancing Access Program Enrollment Form (Spanish)
  • SUNLENCA® (lenacapavir) Program Enrollment Form (English)
• You can also call Advancing Access at 1-800-226-2056 to speak with a program specialist

To register, go to https://advancingaccess.iassist.com/register and follow the steps. If you need help registering, please call the iAssist helpdesk at 1-877-450-4412 for assistance.

All required sections of the enrollment form, along with your signature and your patient’s signature, are required to be completed.

Advancing Access will send a fax to your office letting you know if your patient was eligible for PAP/MAP. Additionally, we will let your patient know via their preferred communication method listed on their enrollment form.

The Gilead Advancing Access Patient Assistance Program (PAP) provides prescribed HIV treatment and COVID-19 medications free of charge to eligible individuals.

The Gilead Advancing Access Medication Assistance Program (MAP) provides prescribed HIV prevention medication free of charge to eligible individuals.

Advancing Access will notify you and your patient if they were eligible based on the preferred communication method your patient listed on the enrollment form.

To be eligible to enroll into PAP/MAP, individuals need to be residents of the United States, Puerto Rico, or US Territories, in addition to meeting other eligibility criteria. Proof of residency may be required.

Standard PAP/MAP enrollment is for up to 12 months, pending ongoing eligibility checks.

If there is ongoing need for support and the patient remains eligible for PAP/MAP, then they can re-enroll.

Advancing Access will reach out to you and your patient 60 days prior to the enrollment end date.

There are several ways to re-enroll eligible individuals into PAP/MAP. You can fax in a new enrollment form or, if you are a registered user of the online enrollment portal, you may be able to re-enroll eligible individuals electronically.

Many individuals who need ongoing PAP/MAP support can be re-enrolled through the online enrollment portal. Follow these steps:

1. Log in to the portal as you normally would
2. On the HOME screen, click on DRAFTS - located in the panel on the left side of the screen
3. Once in the drafts section, click on Re-Verification Drafts. Select or search for specific individual
4. Click on the appropriate individual. You will be routed to the re-enrollment service offering

If you have questions about using this process, please call an Advancing Access program specialist at 1-800-226-2056.

Generally speaking, PAP/MAP is for eligible uninsured individuals without access to additional support and coverage options for obtaining their medication. If your patient is eligible for Medicaid or the AIDS Drug Assistance Program (ADAP), they may not be eligible to re-enroll in PAP/MAP. Please have your patient call Advancing Access to see if they may be able to re-enroll in PAP/MAP.

Please notify Advancing Access by calling 1-800-226-2056 to have the individual withdrawn from PAP/MAP.

• You can use the online enrollment portal, which will give you an immediate determination of an individual’s PAP/MAP eligibility
• You can fax a completed enrollment form to the number on the form. All faxed enrollment forms are reviewed in the order they are received, and you will be notified within 2 business days with a determination of eligibility. Choose your enrollment form:
  • Advancing Access Program Enrollment Form (English)
  • Advancing Access Program Enrollment Form (Spanish)
  • SUNLENCA® (lenacapavir) Program Enrollment Form (English)
• Or, if there is an urgent need to get your patient started, please call an Advancing Access program specialist at 1-800-226-2056

As of May 5, 2025, anyone enrolled in the Advancing Access free drug program can receive their prescribed Gilead medicines via mail. Once a shipment address is confirmed, prescriptions will be mailed as soon as one business day via FedEx overnight delivery to an enrollee’s location of choice to address any privacy concerns—either their home, an alternate address such as a shelter, clinic, FedEx pick-up location, or their healthcare provider’s office should the healthcare provider agree.

New enrollees to Advancing Access may have the option of a 30-day supply of our medicines from a retail pharmacy. Following this first month's fill via retail, the free drug program enrollee will then receive their Gilead medication via mail.

For more details on how to receive your prescription as Gilead is transitioning its Advancing Access free drug program from a retail pharmacy model to a mail order delivery model, please see the FAQs section, Mail order updates, or call 1-800-226-2056.

There are over 40,000 participating retail pharmacies. While using the Pharmacy Finder, enter the pharmacy name and ZIP code to see if the patient’s pharmacy participates in PAP/MAP. If they don’t already have a pharmacy, they can enter their ZIP code to find participating pharmacies near them.

If your patient would like their medication sent directly to them, they can select “mail order delivery” while filling out the enrollment form. Your patient can also call Advancing Access at 1-800-226-2056 for assistance.

The Gilead Co-pay Coupon Card may help eligible, commercially insured individuals lower their out-of-pocket (OOP) costs. It is not available to your patient if they are enrolled in any federally or state-funded prescription drug program, such as Medicare, Medicare Part D, or Medicaid. For more information and to see if your patient is eligible, view co-pay program benefits and terms and conditions.

Your patient can go to the co-pay program page to enroll.

The coverage amount varies depending on the medication. For the most up-to-date amounts, view co-pay program benefits and terms and conditions.

No, the co-pay coupon card does not expire. Once your patient is enrolled in the co-pay program, your patient keeps the same card for the duration of their enrollment in the program. For information about the annual coverage amount for the co-pay program, please visit the co-pay program page.

The patient can go to Replace a Card on the co-pay program page. If help is still needed, the patient can call an Advancing Access program specialist at 1-800-226-2056.

If the patient has not yet activated that card, the patient can go to Enroll on the co-pay program page. If the patient had already activated the card but lost it, the patient should select Replace to retrieve card information. If help is still needed, call an Advancing Access program specialist at 1-800-226-2056.

If a patient is prescribed a different Gilead HIV treatment or HIV prevention medication, they can continue to use the same card for the new medication. However, SUNLENCA® (lenacapavir) has its own specific co-pay cards for which the patient must enroll separately.

Anyone currently enrolled in the Advancing Access free drug program can continue to fulfill their prescription at a retail pharmacy until their one-year program eligibility expires or until December 31, 2025, whichever date comes sooner. After May 5, 2025, anyone who re-enrolls in the program will receive their prescribed Gilead medicines via mail.

Effective May 5, 2025, free drug program new enrollees who need an immediate fill of their prescribed medication may have the option of a 30-day supply of our medicines by retail pharmacy. Following this first month fill via retail, the free drug program enrollee will then receive their Gilead medication via mail. Those utilizing the 30-day supply of our medicines by retail pharmacy can use the Pharmacy Finder to find a participating retail pharmacy.

Once a shipment address is confirmed, prescriptions will be mailed as soon as one business day via FedEx overnight delivery to an enrollee’s location of choice to address any privacy concerns—either their home or an alternate address such as a shelter, clinic, FedEx pick-up location, or their healthcare provider’s office should the healthcare provider agree.

No, eligibility for free medicines does not change—only the way in which enrollees receive their medicines. This does not affect any patient’s eligibility for free medicines.

No, this transition does not impact Gilead’s co-pay coupon program, does not impact who is eligible for co-pay coupon support, and it does not impact how those with commercial insurance receive their Gilead medications.

No, all Gilead Advancing Access support offerings will remain available for all individuals. This includes support from our program specialists to navigate and investigate benefit coverage, alternate coverage assessments, and co-pay coupon support for commercially insured, eligible individuals.

Gilead’s Advancing Access program specialists are available at 1-800-226-2056, from Monday through Friday, from 9 AM to 8 PM ET. We have numerous specialists who are fluent in a variety of languages to ensure support for all individuals. This includes live team agents who are fluent in English and Spanish, as well as a language line that supports more than 200 other languages.

In addition to our program specialists, we also have American Academy of HIV Pharmacy certified pharmacists to answer questions (Monday through Friday, 9 AM to 7:30 PM ET; Saturday, 9 AM to 3 PM ET). Callers will also be able to leave a confidential message any time, and they will receive a call back the next business day.

• Subject to the Gilead Advancing Access® Co-pay Coupon (“Coupon”) Terms and Conditions, this program provides the following financial assistance for the out-of-pocket costs for eligible commercially insured patients with a valid prescription:
  • Up to $9,600 in cost-sharing assistance per calendar year with no monthly limit for the following product:
    • SUNLENCA® (lenacapavir)
  • Up to $7,200 in cost-sharing assistance per calendar year with no monthly limit for the following products:
    • BIKTARVY® (bictegravir/emtricitabine/tenofovir alafenamide)
    • DESCOVY® (emtricitabine/tenofovir alafenamide)
    • GENVOYA® (elvitegravir/cobicistat/emtricitabine/tenofovir alafenamide)
    • TRUVADA® (emtricitabine/tenofovir disoproxil fumarate)
  • Up to $6,000 in patient cost-sharing assistance per calendar year with no monthly limit for the following products:
    • ODEFSEY® (emtricitabine/rilpivirine/tenofovir alafenamide)
    • STRIBILD® (elvitegravir/cobicistat/emtricitabine/tenofovir disoproxil fumarate)
    • COMPLERA® (emtricitabine/rilpivirine/tenofovir disoproxil fumarate)
  • Up to $3,600 in patient cost-sharing assistance per calendar year, with a monthly maximum of $300 in cost-sharing assistance, for the following product:
    • EMTRIVA® (emtricitabine)
  • Up to $600 in patient cost-sharing assistance per calendar year, with a monthly maximum of $50 in cost-sharing assistance, for the following product:
    • TYBOST® (cobicistat)
• As described in the Coupon Terms and Conditions, Gilead may reduce or discontinue the financial assistance available under the Coupon if it determines the patient is subject to an “accumulator adjustment” or “co-pay maximizer” program.
  • If Gilead determines that a patient’s insurer (or its agent) has implemented a program that adjusts patient cost-sharing obligations based on the availability of support under the Coupon program (sometimes called a “co-pay maximizer program”), unless prohibited by law, Gilead may discontinue the cost-sharing assistance available under the Coupon after providing assistance in an amount not to exceed $9,500 or current maximum limit.
  • If Gilead determines that a patient’s insurer (or its agent) has implemented a program that excludes the financial assistance provided under the Coupon program from counting towards the patient’s deductible or out-of-pocket cost limitations (sometimes called an “accumulator adjustment program”), unless prohibited by law, Gilead may reduce the cost-sharing assistance available under the Coupon to a per claim maximum of $25. Please contact Advancing Access® at 1-800-226-2056 to determine if additional cost-sharing assistance is available.
• These Coupon benefits are subject to change for any reason at any time without notice.

• The Gilead Advancing Access® Co-pay Coupon (“Coupon”) provides financial assistance for the out-of-pocket costs for eligible commercially insured patients as described in the Coupon Benefits above. Coupon benefits are limited to financial assistance for patient cost-sharing for the applicable Gilead product only. The Coupon will not cover, and shall not be applied toward, the cost of any dosing procedure or any other healthcare provider service or supply charges or other treatment costs.
• The Coupon can be used only by eligible residents of the US, Puerto Rico, or US territories at participating eligible pharmacies in the US, Puerto Rico, or US territories. Product must be dispensed in the US, Puerto Rico, or US territories. Individuals must be at least 18 years old to use the Coupon themselves or to enroll in the Coupon on behalf of a minor.
• To use the Coupon, the patient (or the patient’s legal representative on behalf of the patient, as applicable) must personally complete the enrollment process for the Coupon. Third-party payers, pharmacy benefit managers, or the agents of either, are prohibited from assisting patients with enrolling in the Coupon. Any decision to enroll in the Coupon must be made voluntarily by the patient.
• The Coupon is not insurance and is not intended to substitute for insurance. Uninsured and cash-paying patients are not eligible to use the Coupon. The Coupon is valid only for prescriptions that are reimbursed by commercial insurance and is not valid for prescriptions that are eligible to be reimbursed:
  • in whole or in part by Medicare or a Medicare Part D plan, Medicaid, TRICARE, VA, DOD, Puerto Rico Government Health Insurance Plan, or any other state or federally funded healthcare benefit program (collectively, “Government Programs”); or
  • by commercial plans or other health or pharmacy benefit programs that reimburse for the entire cost of prescription drugs or prohibit the Coupon’s use.
• Patients who begin receiving prescription benefits from Government Programs at any time must notify Gilead of this fact by contacting Advancing Access at 1-800-226-2056 and will no longer be eligible to use the Coupon.
• The Coupon is limited to one per person and is not transferable. No substitutions are permitted. This Coupon is offered to, and intended for the sole benefit of, eligible patients and may not be utilized for the benefit of third parties, including, without limitation, third-party payers, pharmacy benefit managers, or the agents of either. If Gilead determines that a patient’s insurer has implemented a program that adjusts patient cost-sharing obligations based on the availability of support under the Coupon program (sometimes called a “co-pay maximizer program”), unless prohibited by law, Gilead may discontinue the cost-sharing assistance available under the Coupon after providing assistance in an amount not to exceed $9,500 or current maximum limit. If Gilead determines that a patient’s insurer has implemented a program that excludes the financial assistance provided under the Coupon program from counting towards the patient’s deductible or out-of-pocket cost limitations (sometimes called an “accumulator adjustment program”), unless prohibited by law, Gilead may reduce the cost-sharing assistance available under the Coupon to a per claim maximum of $25. Patients may contact Advancing Access® at 1-800-226-2056 to determine if additional cost-sharing assistance is available.
• The Coupon is only available with a valid prescription. No other purchase is necessary to redeem this offer.
• The Coupon cannot be combined with any other coupon, free trial, discount, prescription savings card, or other offer (including, without limitation, any program offered by a third-party payer or pharmacy benefit manager, or an agent of either, that adjusts patient cost-sharing obligations). Patients are not eligible to use the Coupon for a product if they are currently receiving free drug assistance through Gilead Sciences, Inc. (“Gilead”)’s patient assistance program for that product.
• The Coupon will not reimburse any payments made by Flexible Spending Account (FSA), Health Savings Account (HSA), Health Reimbursement Account (HRA), or any other payor, discount/co-pay program, or other offer.
• Void where prohibited by law, taxed, or restricted.
• Patient, pharmacist, and prescriber agree not to seek reimbursement for all, or any part of the benefit received by the patient through the Coupon. Both patient and pharmacist are each individually responsible for reporting receipt of the Coupon benefit to any insurer, health plan, or other third party who pays for or reimburses any part of the prescription filled using the Coupon, as may be required.
• It is illegal to sell, purchase, trade, or counterfeit, or offer to sell, purchase, trade, or counterfeit the Coupon.
• Certain information pertaining to your use of the Coupon will be shared with Gilead, the sponsor of the Coupon, and its affiliates. The information disclosed will include the patient co-pay ID, pharmacy demographics, prescriber information, and details relating to the coupon claim, such as co-pay amount, insurance details, and the therapy received. For more information, please see the Gilead Privacy Policy at www.gilead.com/privacy.
• Gilead Sciences reserves the right to terminate, rescind, revoke, or modify the Coupon for any reason at any time without notice.

By following this link, you are leaving this Gilead website. Gilead provides these links as a convenience. But these sites are not controlled by Gilead. Gilead is not responsible for their content or your use of them.

This website is intended for US healthcare professionals

RetroSearch is an open source project built by @garambo | Open a GitHub Issue

Search and Browse the WWW like it's 1997 | Search results from DuckDuckGo

HTML: 3.2 | Encoding: UTF-8 | Version: 0.7.3